FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

684421000168109: aluminium hydroxide 400 mg + magnesium hydroxide 400 mg + simethicone 30 mg chewable tablet (medicinal product unit of use)


Status: current, Defined. Date: 31-Jan 2015. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
1371501000168118 aluminium hydroxide 400 mg + magnesium hydroxide 400 mg + simethicone 30 mg chewable tablet (medicinal product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module
1371511000168115 aluminium hydroxide 400 mg + magnesium hydroxide 400 mg + simethicone 30 mg chewable tablet en Synonym Active Case sensitive Australian Medicines Terminology module


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
aluminium hydroxide 400 mg + magnesium hydroxide 400 mg + simethicone 30 mg chewable tablet Is a medicinal product unit of use true Inferred relationship Some
aluminium hydroxide 400 mg + magnesium hydroxide 400 mg + simethicone 30 mg chewable tablet Is a aluminium hydroxide + magnesium hydroxide + simethicone true Inferred relationship Some
aluminium hydroxide 400 mg + magnesium hydroxide 400 mg + simethicone 30 mg chewable tablet has intended active ingredient aluminium hydroxide true Inferred relationship Some 550422600
aluminium hydroxide 400 mg + magnesium hydroxide 400 mg + simethicone 30 mg chewable tablet has Australian BoSS aluminium hydroxide true Inferred relationship Some 550422600
aluminium hydroxide 400 mg + magnesium hydroxide 400 mg + simethicone 30 mg chewable tablet has intended active ingredient magnesium hydroxide true Inferred relationship Some 1195485320
aluminium hydroxide 400 mg + magnesium hydroxide 400 mg + simethicone 30 mg chewable tablet has Australian BoSS magnesium hydroxide true Inferred relationship Some 1195485320
aluminium hydroxide 400 mg + magnesium hydroxide 400 mg + simethicone 30 mg chewable tablet has intended active ingredient simethicone true Inferred relationship Some 1718254664
aluminium hydroxide 400 mg + magnesium hydroxide 400 mg + simethicone 30 mg chewable tablet has Australian BoSS simethicone true Inferred relationship Some 1718254664
aluminium hydroxide 400 mg + magnesium hydroxide 400 mg + simethicone 30 mg chewable tablet has manufactured dose form chewable tablet true Inferred relationship Some
aluminium hydroxide 400 mg + magnesium hydroxide 400 mg + simethicone 30 mg chewable tablet has unit of use tablet true Inferred relationship Some 1718254665

Inbound Relationships Type Active Source Characteristic Refinability Group
Mylanta Double Strength chewable tablet Is a True aluminium hydroxide 400 mg + magnesium hydroxide 400 mg + simethicone 30 mg chewable tablet Inferred relationship Some
aluminium hydroxide 400 mg + magnesium hydroxide 400 mg + simethicone 30 mg chewable tablet, 100 has MPUU True aluminium hydroxide 400 mg + magnesium hydroxide 400 mg + simethicone 30 mg chewable tablet Inferred relationship Some 1

Reference Sets

Australian dialect reference set

Medicinal product unit of use reference set

Back to Start